Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.
Related Posts
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class…
The U.S. Under Trump: Alone in Its Climate Denial
The administration is not only allowing more greenhouse gases. It is undermining the nation’s ability to understand and respond to…
One in Six Abortions Is Done With Pills Prescribed Online, Data Shows
The News A growing share of abortions is now being administered through telemedicine, with clinicians prescribing mail-order abortion pills after…